Stereotactic Body Reirradiation in Gynaecological Cancer: Outcomes and Toxicities from a Single Institution Experience-Reference-Cited by-同舟云学术

Stereotactic Body Reirradiation in Gynaecological Cancer: Outcomes and Toxicities from a Single Institution Experience

Published:2023-10 Issue:10 Volume:35 Page:682-693
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Macchia G.,Pezzulla D.,Cilla S.,Buwenge M.,Romano C.,Ferro M.,Boccardi M.,Ferioli M.,Bonome P.,Lancellotta V.,Tagliaferri L.,Ferrandina G.,Gambacorta M.A.,Morganti A.G.,Deodato F.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference26 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Stereotactic body radiotherapy for pelvic boost in gynecological cancer patients with local recurrence or unsuitable for intracavitary brachytherapy;Cheng;Taiwan J Obstet Gynecol,2021

3. Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT);Arians;Radiat Oncol,2016

4. Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: feasibility and complication;Seo;Asia Pacif J Clin Oncol,2016

5. Stereotactic body radiotherapy for recurrent or oligometastatic uterine cervix cancer: a cooperative study of the Korean Radiation Oncology Group (KROG 14-11);Park;Anticancer Res,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi);International Journal of Gynecologic Cancer;2024-05-31